home / stock / grts / grts news

GRTS News and Press, Gritstone Oncology Inc. From 08/14/19

Stock Information
Company Name: Gritstone Oncology Inc.
Stock Symbol: GRTS
Market: NASDAQ
Website: gritstonebio.com
Menu
GRTS GRTS Quote GRTS Short GRTS News GRTS Articles GRTS Message Board
Get GRTS Alerts

News, Short Squeeze, Breakout and More Instantly...
GRTS - Gritstone Oncology Announces First Patient Dosed with SLATE, its "Off-The-Shelf" Neoantigen Immunotherapy

EMERYVILLE, Calif., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of immunotherapies to fight multiple cancer types, today announced that the first SLATE patient has been dosed. SLATE is an in...
GRTS - Gritstone Oncology EPS misses by $0.01, misses on revenue

Gritstone Oncology (NASDAQ: GRTS ): Q2 GAAP EPS of -$0.63 misses by $0.01 . More news on: Gritstone Oncology, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

GRTS - Gritstone Oncology Reports Second Quarter 2019 Financial Results and Recent Highlights

EMERYVILLE, Calif., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today reported recent business highlights and financial results for ...

GRTS - Canaccord likes CRISPR Therapeutics in today's analyst action

CRISPR Therapeutics ( CRSP +0.8% ) initiated with Buy rating and $72 price target at Canaccord Genuity. More news on: CRISPR Therapeutics AG, Cue Biopharma, Inc., DENTSPLY SIRONA Inc., Healthcare stocks news, Stocks on the move, , Read more ...

GRTS - Gritstone Oncology Announces the Appointment of Dr. Vijay Yabannavar, a Biopharma Leader with Over 30 Years of Experience, as Executive Vice President of Manufacturing and Technical Operations

EMERYVILLE, Calif., July 08, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today announced that Vijay Yabannavar, Ph.D., has joined the company...

GRTS - Gritstone Oncology to Present at Two Upcoming Investor Conferences in June

EMERYVILLE, Calif., June 05, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today announced that Andrew Allen, M.D., Ph.D., co-founder, president ...

GRTS - Apple's WWDC, DuPont's Return And Tariff Anxiety (Stocks To Watch Podcast)

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you can re...
GRTS - Stocks To Watch: Apple's WWDC, DuPont's Return And Tariff Anxiety

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. The week ahead sees Apple (AAPL) host its annual WWDC conference, Walmart (WMT) hol...

GRTS - Gritstone Oncology to Host Event with Oncology Key Opinion Leaders Discussing Neoantigen-based Immunotherapy During ASCO Annual Meeting

EMERYVILLE, Calif., May 30, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today announced that it will webcast an event with key opinion leaders ...

GRTS - Gritstone Oncology beats by $0.04, misses on revenue

Gritstone Oncology (NASDAQ: GRTS ): Q1 GAAP EPS of -$0.62 beats by $0.04 . More news on: Gritstone Oncology, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Previous 10 Next 10